Want to join the ABTA virtual 50 mile Facebook Challenge? Check it out here.
Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
From groundbreaking research to new collaborations at a federal level, discover the top three brain tumor news highlights and milestones for the year.
A first-in-class targeted therapy for low-grade glioma could gain FDA approval as early as spring 2024. Here are three things you should know about the emerging drug “vorasidenib.”
**Sponsored Content**
Referred to as the “center point of progress in modern oncology,” biomarker testing opens up a world of targeted therapies that can guide an oncology treatment plan and turn more patients into survivors.
Always free for patients & caregivers
The need for better brain tumor treatments is greater than ever. That’s why we’re meeting hope head on—because donations lead to research, research leads to better treatments, and better treatments bring us closer to a cure.
The ABTA has been a top resource for brain tumor educational materials for over 50 years. All of our educational brochures are carefully reviewed by brain tumor medical experts, and brain tumor patients and caregivers.. These brochures are 100% free for patients and caregivers.
Donating to the ABTA is a meaningful way to recognize someone whose life has been impacted by a brain tumor. With your gift, you can honor key milestones in a brain tumor survivor’s life, or convey the sense of loss when a friend or loved one loses their battle with this disease.
